Interatrial block and cognitive impairment in the BAYES prospective registry
Related Experiment Video
Updated: Dec 11, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Manuel Martínez-Sellés1, M Esther Martínez-Larrú2, Martin Ibarrola3
1Servicio de Cardiología, Hospital General Universitario Gregorio Marañón, Universidad Europea, Universidad Complutense, Madrid, Spain; CIBERCV, Madrid, Spain.
Insights
Interatrial block (IAB), a heart condition, is linked to cognitive impairment (CI) in older adults with heart disease. Both partial and advanced IAB predict future cognitive decline.
Area of Science:
- Cardiology
- Neurology
- Geriatrics
Background:
- A potential link between interatrial block (IAB) and dementia has been proposed.
- This study aimed to investigate the association between IAB and cognitive impairment (CI).
Purpose of the Study:
- To assess the relationship between interatrial block (IAB) and cognitive impairment (CI) in elderly patients with structural heart disease.
- To determine if IAB is an independent predictor of cognitive decline.
Main Methods:
- Prospective study of 552 patients aged 70+ with structural heart disease in sinus rhythm.
- Cognitive function assessed using the Pfeiffer test at baseline and every 6 months.
- Median follow-up of 22 months.
Main Results:
- 30 patients (5.4%) had baseline CI. Higher prevalence of advanced IAB in patients with CI (46.7% vs 23.4%).
- Advanced IAB independently associated with baseline CI (OR 4.9).
- Both partial and advanced IAB independently associated with CI at follow-up (HR 1.98 and 2.04, respectively).
Conclusions:
- Advanced IAB is associated with baseline cognitive impairment in elderly patients with structural heart disease in sinus rhythm.
- Partial and advanced IAB are associated with the development of cognitive impairment during follow-up.
Background:
An association between interatrial block (IAB) (P wave duration ≥120 ms) and dementia has been suggested. Our objective was to assess the association of IAB with cognitive impairment (CI).
Methods:
The prospective BAYES registry included 552 patients ≥70 years with structural heart disease without documented atrial fibrillation. Cognitive ability was assessed at baseline and every 6 months with the Pfeiffer test. The median follow-up was 22 months.
Results:
Thirty patients (5.4%) had baseline CI, 20 patients with mild CI and 10 with moderate CI. Compared to patients without CI, patients with CI had higher mean age (80.4 ± 6.5 vs. 76.8 ± 5.4 years) and higher prevalence of advanced IAB (with biphasic P-wave ± in inferior leads) (14 [46.7%] vs. 122 [23.4%], p < .01). The prevalence of baseline CI was 2.7% in normal P-wave, 5.1% in partial IAB, and 10.3% in advanced IAB, p < .001. Advanced IAB was independently associated with baseline CI (odds ratio 4.9, 95% confidence interval 1.4-16.5), this was not the case with partial IAB (odds ratio 2.1, 95% confidence interval 0.5-7.4). The independent association with CI at follow-up existed both for partial IAB (hazard ratio 1.98, 95% confidence interval 1.18-3.33) and advanced IAB (hazard ratio 2.04, 95% confidence interval 1.19-3.51).
Conclusion:
In patients aged 70 years or more with structural heart disease who are in sinus rhythm advanced IAB is associated with baseline CI. There is also an association of partial and advanced IAB with CI during follow-up.
More Related Videos
07:42Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure Drugs: β-Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Coronary Artery Disease IV: Preventive Measures
Cardiomyopathy IV: Restrictive Cardiomyopathy
Dysrhythmias IV: Characteristics of Bradyarrhythmias